BCO · Insider Trading
The Brink's Company
Every open-market purchase and sale reported by BCO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Kurt B McMaken | EVP, Chief Financial Officer | A | +66 deriv. | — |
| 2026-10-02 | Michael J Herling | Director | A | +160 | — |
| 2026-10-02 | Adrian Button | EVP | A | +53 deriv. | — |
| 2026-10-02 | Elizabeth A Galloway | EVP and CHRO | A | +43 deriv. | — |
| 2026-10-02 | Mijares Guillermo Eduardo Peschard | EVP | A | +56 deriv. | — |
| 2026-10-02 | Richard M. Eubanks | President and CEO | A | +118 deriv. | — |
| 2026-10-02 | Kristen Williams Cook | EVP & CLO | A | +42 deriv. | — |
| 2026-10-02 | Ian D Clough | Director | A | +157 | — |
| 2026-10-02 | Paul G Boynton | Director | A | +147 deriv. | — |
| 2026-09-03 | Elizabeth A Galloway | EVP and CHRO | A | +6 deriv. | — |
| 2026-09-03 | Michael J Herling | Director | A | +13 deriv. | — |
| 2026-09-03 | Mijares Guillermo Eduardo Peschard | EVP | A | +2 deriv. | — |
| 2026-09-03 | Adrian Button | EVP | A | +0 deriv. | — |
| 2026-09-03 | Richard M. Eubanks | President and CEO | A | +109 deriv. | — |
| 2026-09-03 | Timothy Joseph Tynan | Director | A | +21 deriv. | — |
| 2026-09-03 | Paul G Boynton | Director | A | +84 deriv. | — |
| 2026-09-03 | Kurt B McMaken | EVP, Chief Financial Officer | A | +12 deriv. | — |
| 2026-09-03 | Kristen Williams Cook | EVP & CLO | F | −729 | −$78.35K |
| 2026-09-02 | Kristen Williams Cook | EVP & CLO | A | +39 deriv. | — |
| 2026-09-02 | Adrian Button | EVP | A | +49 deriv. | — |
| 2026-09-02 | Elizabeth A Galloway | EVP and CHRO | A | +40 deriv. | — |
| 2026-09-02 | Kurt B McMaken | EVP, Chief Financial Officer | A | +53 deriv. | — |
| 2026-09-02 | Richard M. Eubanks | President and CEO | A | +109 deriv. | — |
| 2026-09-02 | Mijares Guillermo Eduardo Peschard | EVP | A | +52 deriv. | — |
| 2026-08-04 | Kristen Williams Cook | EVP & CLO | A | +36 deriv. | — |
| 2026-08-04 | Elizabeth A Galloway | EVP and CHRO | A | +37 deriv. | — |
| 2026-08-04 | Mijares Guillermo Eduardo Peschard | EVP | A | +48 deriv. | — |
| 2026-08-04 | Richard M. Eubanks | President and CEO | A | +100 deriv. | — |
| 2026-08-04 | Kurt B McMaken | EVP, Chief Financial Officer | A | +49 deriv. | — |
| 2026-08-04 | Adrian Button | EVP | A | +45 deriv. | — |
| 2026-07-02 | Kristen Williams Cook | EVP & CLO | A | +45 deriv. | — |
| 2026-07-02 | Adrian Button | EVP | A | +57 deriv. | — |
| 2026-07-02 | Ian D Clough | Director | A | +167 | — |
| 2026-07-02 | Elizabeth A Galloway | EVP and CHRO | F | −3,240 | −$306.15K |
| 2026-07-02 | Michael J Herling | Director | A | +171 | — |
| 2026-07-02 | Paul G Boynton | Director | A | +158 deriv. | — |
| 2026-07-02 | Mijares Guillermo Eduardo Peschard | EVP | A | +60 deriv. | — |
| 2026-07-02 | Richard M. Eubanks | President and CEO | A | +126 deriv. | — |
| 2026-07-02 | Kurt B McMaken | EVP, Chief Financial Officer | A | +62 deriv. | — |
| 2026-06-03 | Kurt B McMaken | EVP, Chief Financial Officer | A | +13 deriv. | — |
| 2026-06-03 | Timothy Joseph Tynan | Director | A | +22 deriv. | — |
| 2026-06-03 | Adrian Button | EVP | A | +0 deriv. | — |
| 2026-06-03 | Mijares Guillermo Eduardo Peschard | EVP | A | +2 deriv. | — |
| 2026-06-03 | Kristen Williams Cook | EVP & CLO | A | +0 deriv. | — |
| 2026-06-03 | Michael J Herling | Director | A | +14 deriv. | — |
| 2026-06-03 | Richard M. Eubanks | President and CEO | A | +115 deriv. | — |
| 2026-06-03 | Paul G Boynton | Director | A | +89 deriv. | — |
| 2026-06-03 | Elizabeth A Galloway | EVP and CHRO | A | +7 deriv. | — |
| 2026-06-02 | Mijares Guillermo Eduardo Peschard | EVP | A | +54 deriv. | — |
| 2026-06-02 | Elizabeth A Galloway | EVP and CHRO | A | +42 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Richard M. Eubanks | President and CEO | 183,871 | $19.99M |
| Kurt B McMaken | EVP, Chief Financial Officer | 76,384 | $8.31M |
| Elizabeth A Galloway | EVP and CHRO | 33,795 | $3.67M |
| Ian D Clough | Director | 31,307 | $3.40M |
| Daniel J Castillo | EVP | 22,188 | $2.41M |
| Susan E Docherty | Director | 20,378 | $2.22M |
| Michael J Herling | Director | 19,669 | $2.14M |
| Michael Nissim Gabay | EVP | 16,663 | $1.81M |
| James K Parks | EVP | 16,295 | $1.77M |
| Lindsay K. Blackwood | EVP & General Counsel | 15,629 | $1.70M |
| Kathie J. Andrade | Director | 12,679 | $1.38M |
| Kristen Williams Cook | EVP & CLO | 9,964 | $1.08M |
| Arthelbert Louis Parker | Director | 8,447 | $918.44K |
| Nader Rida Antar | EVP | 5,765 | $626.83K |
| Michael E Sweeney | Controller | 5,755 | $625.74K |
| Keith R Wyche | Director | 5,526 | $600.84K |
| Mijares Guillermo Eduardo Peschard | EVP | 5,085 | $552.89K |
| Adrian Button | EVP | 4,943 | $537.45K |
| Timothy Joseph Tynan | Director | 1,500 | $163.09K |
| Adnane Louridi | Chief Accounting Officer | 1,420 | $154.40K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BCO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.